MarketBeat
Sun, May 10, 2026 astatine 4:04 PM CDT 7 min read
Key Points
-
Interested successful Hinge Health Inc.? Here are 5 stocks we similar better.
-
Hinge Health bushed Q1 expectations with gross of $182 million, up 47% twelvemonth implicit year, and raised its full-year 2026 guidance. The institution besides posted stronger profitability, including an 85% gross margin, $46 cardinal successful non-GAAP operating income, and $42 cardinal successful escaped currency flow.
-
AI and automation are driving operating leverage, helping Hinge Health standard much efficiently and grow margins. Management said much than 95% of clinician hours tied to accepted carnal therapy person been automated, contributing to higher margins and a amended outlook for operating income.
-
The institution is expanding beyond musculoskeletal care with the motorboat of Migraine Care, its archetypal programme extracurricular MSK. Early adoption has been strong, but absorption expects lone minimal gross publication successful 2026, with much meaningful interaction apt successful 2027.
-
MarketBeat Week successful Review – 02/23 - 02/27
Hinge Health (NYSE:HNGE) reported first-quarter 2026 results that topped its anterior outlook and raised its full-year guidance, citing stronger-than-expected subordinate engagement, maturation successful eligible lives and continued operating leverage from artificial quality and automation.
Co-Founder and CEO Daniel Perez said the institution generated $182 cardinal successful first-quarter revenue, up 47% from $124 cardinal successful the year-earlier play and supra its guidance scope of $171 cardinal to $173 million. Last-12-months calculated billings roseate 52% twelvemonth implicit twelvemonth to $770 million.
→ Wells Fargo’s Comeback Is Real—But Not Risk-Free
-
Hinge Health’s AI Moat Might Be Its Patient Movement Data
“We had a beardown commencement to the year,” Perez said, adding that Hinge Health’s concern is “scaling efficiently” arsenic AI and automation investments assistance the institution service much members portion expanding margins.
Profitability Expands arsenic Guidance Moves Higher
Hinge Health reported an 85% gross borderline for the quarter, up from 81% successful the archetypal 4th of 2025. Non-GAAP operating income was $46 million, exceeding the company’s anterior guidance scope of $30 cardinal to $32 million. Operating borderline was 25%, compared with 12% a twelvemonth earlier.
→ Rocket Lab Posts Record Q1 Revenue, Raises Q2 Guidance
-
Notable Newcomers: These 2025 IPOs Dominated the Year
Free currency travel totaled $42 cardinal successful the quarter, compared with $4 cardinal successful the prior-year period, representing a escaped currency travel borderline of 23%. CFO James Budge said the institution ended the 4th with $407 cardinal successful currency and currency equivalents. Hinge Health besides repurchased 2.5 cardinal shares during the 4th for $105 million, and diluted weighted mean stock number fell to 82.4 cardinal shares.

1 hour ago
3





English (CA) ·
English (US) ·
Spanish (MX) ·